Trophoblasts express Fas ligand: A proposed mechanism for immune privilege in placenta and maternal invasion

Molecular Human Reproduction

Volumn 3, Issue 8, 1997, Pages 655-662

  Uckan, D ^a   Steele, A ^b   Cherry, ^a   Wang, B Y ^a   Chamizo, W ^b   Koutsonikolis, A ^a   Gilbert Barness, E ^c   Good, R A ^a  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

^b JOHNS HOPKINS ALL CHILDREN S HOSPITAL   (United States)

^c TAMPA GENERAL HOSPITAL   (United States)

Author keywords

Apoptosis; Fas ligand; Immune privilege; Placenta; Trophoblast

Indexed keywords

FAS ANTIGEN; FAS LIGAND; FASLG PROTEIN, HUMAN; MEMBRANE PROTEIN; MESSENGER RNA;

APOPTOSIS; ARTICLE; BIOSYNTHESIS; CYTOLOGY; FEMALE; GENETIC TRANSCRIPTION; HUMAN; IMMUNOLOGY; METHODOLOGY; PHYSIOLOGY; PLACENTA; POLYMERASE CHAIN REACTION; PREGNANCY; TROPHOBLAST;

ANTIGENS, CD95; APOPTOSIS; FAS LIGAND PROTEIN; FEMALE; HUMANS; MEMBRANE GLYCOPROTEINS; PLACENTA; POLYMERASE CHAIN REACTION; PREGNANCY; RNA, MESSENGER; TRANSCRIPTION, GENETIC; TROPHOBLASTS;

EID: 0031196479     PISSN: 13609947     EISSN: None     Source Type: Journal    
DOI: 10.1093/molehr/3.8.655     Document Type: Article

References (50)

1. Abrahamsohn, P.A. and Zorn, T.M.T. (1993) Implantation and decidualization in rodents. J. Exp. Zool., 266, 603-628.
2. Baer, R. (1994) Bcl-2 breathes life into embryogenesis. Am. J. Pathol.,145, 7-10.
3. Barcena, A., Park, S.W., Banapour, D. et al. (1996) Expression of Fas/CD95 and Bcl-2 by primitive hemopoietic progenitors freshly isolated from human fetal liver. Blood.88, 2013-2025.
4. Bellgrau, D., Gold, D., Selawry, H. et al (1995) A role for CD95 ligand in preventing graft rejection. Nature,377, 630-632.
5. Berke, G. (1995) The CTL's kiss of death. Cell,81, 9-12.
6. Chaouat, G., Meliani, A.A., Martal, J. et al. (1995) IL-10 prevents naturally occurring fetal loss in the CBAXDBA/2 mating combination and local defect in EL-10 production in this abortion-prone combination is corrected by in vivo injection of IFN-t. J Immunol.,154, 4261-4-268.
7. Cherry, S.H. and Merkatz, I.R. (eds) (1991) Complications of Pregnancy. Williams and Wilkins, Baltimore, pp. 386-392.
8. French, L E., Hahne, M., Viard, I. et al (1996) Fas and Fas Ligand in embryos and adult mice: ligand expression in several immune-privileged tissues and co-expression m adult tissues characterized by apoptotic cell turnover J. Cell Biol.,133, 335-343.
9. Fox, H. (ed.) (1978) Pathology of the Placenta. W.B. Saunders, London, pp. 1-35 and 326-341.
10. Gabbe, S.G., Niebyl, J.R. and Simpson, J.L. (eds) (1991) Obstetrics/Normal and Problem Pregnancies. Churchill Livingstone. New York, pp 41-43 and p 101.
11. Compel, A., Sabourin, J.C., Martin, A et al. (1994) Bcl-2 expression in normal endometrium during menstrual cycle. Am. J. Pathol.,144, 1195-1202.
12. Griffith, T.S., Brunner, T., Fletcher, S.M. et al. (1995) Fas ligand-induced apoptosis as a mechanism of immune privilege. Science,270, 1189-1192.
13. Hahne, M., Rimoldi, D., Schroter, M. et al. (1996) Melanoma cell expression of Fas (Apo-1/CD95) ligand: implications for tumor immune escape. Science,274, 1363-1366.
14. Hockenbery, D., Zutter, M., Hickey, W et al. (1991) Bcl-2 protein is topographically restricted in tissues characterized by apoptotic cell death. Proc. Natl. Acad. Sci. USA,88, 6961-6965.
15. Itoh, N , Tsujimoto, Y. and Nagata, S. (1993) Effect of Bcl-2 on Fas antigen-mediated cell death. J. Immunol.,151, 621-627.
16. Jaattela, M., Benedict, M., Tewari, M et al. (1995) Bcl-x and Bcl-2 inhibit TNF and Fas-induced apoptosis and activation of phospholipase A2 in breast carcinoma cells. Oncogens,10, 2297-2305.
17. Kurman, R.J. (ed.) (1994) Blaustein's Pathology of the Female Genital Tract Springer Verlag, New York, pp. 976-1036.
18. Kliman, H.J , Feinberg, R.F. and Haimowitz, J.E. (1990) Human trophoblast-endometrial interactions in an in vitro suspension culture system. Placenta, 11, 349-367.
19. Lalani, E.M.A., Bulmer, J.N. and Wells. M. (1987) Peroxidase-labelled lectin-binding of human extravillous trophoblast. Placenta,8, 15-26.
20. Loke, Y.W. and King, A. (1990) Current topic: Interferon and human placental development. Placenta,11, 291-299.
21. Lu, Q.L., Poulsom, R., Wong, L. et al. (1993) Bcl-2 expression in adult and embryonic non-hematopoietic tissues J. Pathol.169, 431-437.
22. Marzusch, K., Ruck, P., Horny, H.P. et al. (1995) Expression of the p53 tumour suppressor gene in human placenta: an immunohistochemical study. Placenta.16, 101-104
23. McMaster, M.T , Librach, C.L., Zhou, Y. et al. (1995) Human placental HLA-G expression is restricted to differentiated cytotrophoblasts. L. Immunol., 154, 3771-3778.
24. Moulton, B.C. (1993) Transforming growth factor-b stimulated endometrial stromal apoptosis in vitro. Endocrinology,134, 1055-1060.
25. Nagata, S. (1996) Fas ligand and immune evasion. Nature Med.,2,1306-1307.
26. Nagata, S. and Goldstein, P. (1995) The Fas death factor Science,267,1449-1456.
27. Nagata, S. and Suda, T. (1995) Fas and Fas ligand: Ipr and gld mutations. Immunol. Today,16, 39-43.
28. Nuovo, G.J. and Forde, A. (1995) In improved system for reverse transcriptase in sim PCR. J. Histotechnol.,18, 295-299.
29. O'Connell, I, O'Sullivan, G.C., Collins, J.K. et al. (1996) The Fas counterattack! Fas-mediated T cell killing by colon cancer cells expressing Fas ligand. J. Exp. Med.,184, 1075-1082.
30. Otsuki, Y, Misaki, O., Sugimoto, O. et al. (1994) Cyclic bcl-2 gene expression in human uterine endometrium during menstrual cycle. Lancet,344, 28-29.
31. Piacentini, M. and Autuori, F. (1994) Immunohistochemical localization of tissue transglutaminase and Bcl-2 in rat uterine tissues during embryo implantation and postpartum involution. Differentiation,57, 51-61.
32. Quirk, S.M., Cowan, R.G., Joshi, S.G. et al. (1995) Fas antigen-mediated apoptosis in human granulosa/luteal cells. Biol. Reprod.,52, 279-287.
33. Roncalli, M., Bulfamante, G., Viale, G. et al. (1994) C-myc and tumor suppressor gene product expression in developing and term human trophoblast. Placenta, 15, 399-409.
34. Scott, D.W., Grdina, T. and Shi, Y. (1996) T cells commit suicide, but B cells are murdered! J. Immunol.,156, 2352-2356.
35. Simpson, E. (1996) Why the baby isn't thrown out. Curr. Biol., 6, 43-44.
36. St. Jacques, S., Dadi, H.K. and Letarte, M. (1993) CD44 in human placenta-localization and binding to hyaluronic acid. Placenta,14, 25-39.
37. Steele, A., Uckan, D., Chamizo, W. et al (1997) An optimized immuno-histochemical protocol for both manual and automated staining of formalin-fixed, parffin-embedded huamn placenta for demonstration and analyses of Fas, Fas-L and bcl-2. J. Histotechnol., 20, in press.
38. Strand, S., Hofmann, W.J., Hug, H et al. (1996) Lymphocyte apoptosis induced by CD95 (Apo-1/Fas) ligand-expressing tumor cells - a mechanism of immune evasion? Nature Med., 2, 1361-1366.
39. Streilein, J.W. (1995) Unraveling immune privilege. Science,270, 1158-1159
40. Tabibzadeh, S. and Babaknia, A. (1995) The signals and molecular pathways in implantation, a symbiotic interaction between blastocyst and endometrium involving adhesion and tissue invasion. Hum Reprod.,10, 1579-1602.
41. Tabibzadeh, S., Zupi, E., Babaknia, A. et al. (1995a) Site and menstrual cycle-dependent expression of proteins of the tumour necrosis factor (TNF) receptor family, and Bcl-2 oncoprotein and phase specific production of TNF alpha in human endometrium. Hum. Reprod.,10, 277-286.
42. Tabibzadeh, S., Kong, Q F., Babaknia, A. et al. (1995b) Progressive rise in the expression of interleukin-6 in human endometrium during menstrual cycle is initiated during the implantation window. Hum. Reprod.,10, 2793-2799.
43. Tabibzadeh, S, Kong, Q.F., Satyaswaroop, P.G. et al. (1996) Heat shock proteins in human endometrium throughout the menstrual cycle. Hum. Reprod.11, 633-40.
44. Tafuri, A., Alferink, J., Moller, P. et al. (1995) T cell awareness of paternal alloantigens during pregnancy. Science,270, 630-632.
45. Vaux, D.L. (1995) Ways around rejection. Nature.377, 576-577.
46. Wegmann, T.G., Lin, H., Guilbert, L. et al. (1993) Bidirectional cytokine interactions in the maternal-fetal relationship: Is successful pregnancy a TH2 phenomenon? Immunol. Today,14, 353-356.
47. Weller, M., Malipiero, U., Aguzzi, A. et al (1995) Proto-oncogene bcl-2 gene transfer abrogates Fas/Apo-1 antibody-mediated apoptosis of human malignant glioma cells and confers resistance to chemotherapeutic drugs and therapeutic irradiation. J. Clin. Invest.,95, 2633-2643.
48. Welsh, A.O. (1993) Uterine cell death during implantation and early placentation. Microsc. Res. Tech.,25, 223-224.
49. Wilbanks, G.A. and Streilein, J.W. (1992) Fluids from immune privileged sites endow macrophages with the capacity to induce antigen-specific immune deviation via a mechanism involving transforming growth factor-beta. Eur. J. Immunol.,22, 1031-1036.
50. Yang, Y, Geraghty, D.E. and Hunt, J.S. (1995) Cytokine regulation of HLA-G expression in human trophoblast cell lines. J. Reprod. Immunol.,29, 179-195.